Reported 1 day ago
Clover Health Investments, Corp. (NASDAQ:CLOV) experienced a significant jump of 19.4% on Friday, closing at $3.82 following a 'buy' recommendation from Zacks Research. This upgrade comes amid rising earnings estimates, with analysts projecting the company to earn $0.10 per share for the fiscal year ending December 2025, maintaining the previous year's figure. Clover's results for the third quarter are scheduled for release on November 6, 2025.
Source: YAHOO